Trial Details
COMPLETEDBasic Information
| Clinical ID | c1350 |
|---|---|
| Identifier | NCT05530122 |
| Trial Title | Prognosis in UC After First Biological |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: infliximab, adalimumab, golimumab, vedolizumab, ustekinumab |
Participant Information
| Sponsor | Tampere University Hospital |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2025-01-09 |
|---|---|
| Primary Completion Date | 2025-01-20 |
| Completion Date | 2022-08-26 |